Genome-wide CRISPRi-seq identified ferredoxin-NADP reductase FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa
Yu Zhang, Tingting Zhang, Xue Xiao, Yejun Wang, Adam Kawałek, Jinzhao Ou, Anmin Ren, Wenhao H. Sun, Vincent de Bakker, Yujie Liu, Yuelong Li, Liang Yang, Liang Ye, Ning Jia, Jan‐Willem Veening, Xue Liu
The paper uses CRISPRi-seq to identify FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa, enhancing gallium's efficacy against infections.
Nature Communications · Jul 1, 2025Peer-reviewedMicrobiology